A new mutant in the yellow-bellied cotton rat.

D. McWhirter,P. Dalby,J. H. Asher

Journal of Heredity

Abstract:

What problem does this paper attempt to address?

Prevention and Treatment of Anaphylactoid Reaction to Ionic and Nonionic Iodinated Contrast Media

PANG Ping-juan,XU Hui-min,XU Xiang

DOI: https://doi.org/10.3969/j.issn.1007-9572.2010.12.047

2010-01-01

Chinese General Practice

Abstract:This paper is aimed to approach the prevention and treatment of anaphylactoid reaction to Ionic and nonionic iodinated contrast media,comparing the pertinent literatures on allergy test of contrast media.Based on the guidelines of America and Europe,methods of prevention and treatment of anaphylactoid reaction to contrast media are proposed.Sensitivity tests are recommended to be done by contrast media.
Managing Adverse Reactions to Contrast Agents

Brian Boyd,Carlos A. Zamora,Mauricio Castillo

DOI: https://doi.org/10.1016/j.mric.2017.06.008

IF: 1.376

2017-11-01

Magnetic Resonance Imaging Clinics of North America

Abstract:Adverse reactions to iodinated and gadolinium-based contrast agents occur at an incidence of less than 1%. Although the exact pathophysiologic mechanisms are not completely understood, the treatment regimens are well accepted. Skin testing may be helpful in patients with a history of severe allergiclike reaction to aid in the selection of alternative contrast agents. Premedication should only be used for a history of allergiclike reaction. Imaging team members should be familiar with signs and symptoms of contrast reactions to allow for prompt assessment and treatment. A plan of action should be in place for contrast reactions and rehearsed regularly.

radiology, nuclear medicine & medical imaging
Adverse Reactions to Contrast Material: A Canadian Update

Alexander Morzycki,Anuj Bhatia,Kieran J. Murphy

DOI: https://doi.org/10.1016/j.carj.2016.05.006

2017-05-01

Canadian Association of Radiologists Journal

Abstract:Imaging techniques frequently employ contrast agents to improve image resolution and enhance pathology detection. These gadolinium- and iodine-based media, although generally considered safe, are associated with a number of adverse effects ranging from mild to severe. Reactions are classified as either anaphylactoid (“anaphylaxis-like”) or nonanaphylactoid, depending on a number of elements that will be reviewed. Herein, we have summarized predisposing risk factors for adverse events resulting from the use of contrast, their associated pathophysiological mechanisms as well as known prophylaxis for the antitreatment of high-risk patients. In the unlikely event that a serious adverse reaction does occur, we have provided a comprehensive summary of treatment protocols. Our goal was to thoroughly evaluate the current literature regarding adverse reactions to radiocontrast agents and provide an up to date review for the health care provider.
Prevention and Management of Adverse Reactions Induced by Iodinated Contrast Media

Yi-Wei Wu,Kheng Song Leow,Yujin Zhu,Cher Heng Tan

DOI: https://doi.org/10.47102/annals-acadmedsg.v45n4p157

2016-04-15

Annals of the Academy of Medicine, Singapore

Abstract:Iodinated radiocontrast media (IRCM) is widely used in current clinical practice. Although IRCM is generally safe, serious adverse drug reactions (ADRs) may still occur. IRCM-induced ADRs may be subdivided into chemotoxic and hypersensitivity reactions. Several factors have been shown to be associated with an increased risk of ADRs, including previous contrast media reactions, history of asthma and allergic disease, etc. Contrast media with lower osmolality is generally recommended for at-risk patients to prevent ADRs. Current premedication prophylaxis in at-risk patients may reduce the risk of ADRs. However, there is still a lack of consensus on the prophylactic role of premedication. Contrast-induced nephropathy (CIN) is another component of IRCM-related ADRs. Hydration remains the mainstay of CIN prophylaxis in at-risk patients. Despite several preventive measures, ADRs may still occur. Treatment strategies for potential contrast reactions are also summarised in this article. This article summarises the pathophysiology, epidemiology and risk factors of ADRs with emphasis on prevention and treatment strategies. This will allow readers to understand the rationale behind appropriate patient preparation for diagnostic imaging involving IRCM. Key words: Contrast-induced nephropathy, Hypersensitivity, Premedication

medicine, general & internal
[Prophylaxis and treatment of side effects due to iodinated contrast media relevant to radiological practice]

C Becker

DOI: https://doi.org/10.1007/s00117-007-1550-4

Abstract:Increased utilization of iodinated contrast media may be associated with increased incidence of adverse events. The most important side effects include contrast-induced nephropathy, anaphylactoid reaction, thyrotoxicosis, and extravasation. In patients with moderate renal dysfunction, saline hydration and reduction of contrast media volume are recommended. No regime to prevent anaphylactoid reactions has yet proven to be efficient. If subclinical hyperthyroidism has been determined, prophylaxis with sodium perchlorate is advised. Contrast-induced nephropathy is commonly transient and needs to be followed over time. Mild general anaphylactoid reactions may be treated with antihistaminic drugs and corticosteroids. Furthermore the choice of the X-ray contrast media might influence the risk of any adverse effects.
Intrinsic alterations of pro‐inflammatory mediators in unstimulated and TLR‐2 stimulated keratinocytes from atopic dermatitis patients

M. Niebuhr,A. Heratizadeh,K. Wichmann,I. Satzger,T. Werfel

DOI: https://doi.org/10.1111/j.1600-0625.2011.01277.x

2011-06-01

Experimental Dermatology

Abstract:Abstract: In many patients with atopic dermatitis (AD), the disease is complicated by their enhanced susceptibility to bacterial skin infections, especially with Staphylococcus aureus (S. aureus). Resistance to bacterial skin infections, e.g. S. aureus, is based on the function of intact innate immune mechanisms in the epidermis, mainly provided by keratinocytes. Toll‐like receptor (TLR)‐2 recognizes components of S. aureus and is known to be expressed on keratinocytes. The aim of this study was to investigate intrinsic TLR‐2 expression and cytokine secretion upon TLR‐2 stimulation with peptidoglycan (PGN), lipoteichoic acid (LTA) and N‐palmitoyl‐S‐[2,3‐bis(palmitoyl)‐(2RS)‐propyl]‐(R)cysteinyl‐alanyl‐glycine (Pam3Cys) in keratinocytes from patients with AD compared to healthy controls. Human primary keratinocytes (HPKs) were cultivated from hair follicles of patients with AD and non‐atopic healthy controls and stimulated with Pam3Cys, LTA and PGN. TLR‐2, TLR‐1 and TLR‐6 expression were investigated at the mRNA level. IL‐6, IL‐8, chemokine C‐C motif ligand (CCL)‐20 and MMP‐9 production were studied at the protein level. TLR‐2, TLR‐1 and TLR‐6 were expressed on both HPKs from patients with AD as well as healthy controls without significant differences between these groups. HPKs from patients with AD had an intrinsically reduced capacity to produce IL‐6, IL‐8, CCL‐20 and MMP‐9 and responded less to TLR‐2 stimulation compared to HPKs from healthy controls. Our findings show evidence for intrinsic alterations in HPKs from patients with AD compared to healthy controls and diminished responses upon TLR‐2 stimulation that might contribute to the enhanced susceptibility to skin infections with S. aureus.
Iodine and Gadolinium Contrast Reactions: What Is the Risk and Role of Premedication, Abbreviated Protocols, Prior History of Reactions, and Cross-Reactivity?

Benjamin M Mervak,Jennifer S McDonald

DOI: https://doi.org/10.1016/j.rcl.2024.02.014

Abstract:Immediate hypersensitivity reactions to iodinated contrast media and gadolinium-based contrast media can be life-threatening. While corticosteroid premedication or agent-switching may mitigate risk, evidence is largely indirect and based on historical studies; recent literature refutes the efficacy. Guidance on premedication varies between organizations worldwide. No strategy eliminates reactions, and indirect consequences of premedication are substantial. Accelerated regimens are often used for emergencies, but are of questionable efficacy. Identifying "high-risk" patients is complex, but a history of reactions (to the same contrast class) is the biggest risk factor.
Trends in Adverse Events After IV Administration of Contrast Media

Sachiko T. Cochran,Karen Bomyea,James W. Sayre

DOI: https://doi.org/10.2214/ajr.176.6.1761385

2001-06-01

American Journal of Roentgenology

Abstract:OBJECTIVE: Data collected from 1985 to 1999 on adverse events after the IV administration of contrast media were evaluated to identify trends.MATERIALS AND METHODS: Data collected on 391 adverse events after 90,473 administrations of iodinated contrast media and 19 events after 28,340 administrations of gadolinium were evaluated. Reactions were graded as mild, moderate, or severe. Data were also collected regarding contrast extravasation.RESULTS: When only ionic iodinated contrast material was used, the adverse reaction rate was 6-8%. With the selective use of contrast material, the adverse reaction rate was 0.6% and 0.7%, respectively, for ionic and nonionic agents. The rate decreased to 0.2% with the universal use of nonionic agents. More than 90% of adverse reactions were allergic-like. Seven severe reactions (0.05%) and no deaths occurred in the ionic group. During the selective use period, one death occurred in the nonionic group. No severe reactions or deaths occurred during the first 5 years of universal nonionic use. Since then, 10 severe reactions (0.02%) and one death have occurred. Seven reactions occurred in patients after helical CT angiography. The extravasation rate for iodinated contrast material has remained constant at 0.3-0.4% annually. The adverse reaction rate to gadolinium contrast material was 0.06%.CONCLUSION: Mild and moderate adverse events are more common with ionic contrast material than with nonionic. Most reactions are allergic-like. Severe reactions are seen equally with ionic and nonionic contrast material but differ in type. The reactions were allergic-like in the ionic group but were predominantly attributable to cardiopulmonary decompensation in the nonionic group. Helical CT angiography may play a role in reactions.

radiology, nuclear medicine & medical imaging
On q-Integral Transforms and Their Applications

Durmuş Albayrak,S. Purohit,Faruk Uçar

Abstract:In this paper, we introduce a q-analogue of the P-Widder transform and give a Parseval-Goldstein type theorem. Furthermore, we evaluate the q-Laplace transform of a product of q-Bessel functions. Several special cases of our results are also pointed out.
Safe Use of Contrast Media: What the Radiologist Needs to Know

Katrina R Beckett,Andrew K Moriarity,Jessica M Langer

DOI: https://doi.org/10.1148/rg.2015150033

Radiographics

Abstract:Iodinated and gadolinium-based contrast media are used on a daily basis in most radiology practices. These agents often are essential to providing accurate diagnoses, and are nearly always safe and effective when administered correctly. However, reactions to contrast media do occur and can be life threatening. Therefore, it is critical for faculty and staff to know how reactions to contrast agents manifest and how to treat them promptly. The decline in renal function seen occasionally after intravenous administration of iodinated contrast agents is poorly understood and likely multifactorial, and its association with the contrast medium may be overemphasized. However, it is important that radiologists be aware of current understanding and strategies to decrease the incidence of renal dysfunction. Nephrogenic systemic fibrosis, a skin disease, is an adverse reaction related to use of some gadolinium-based contrast agents in patients with chronic renal failure. The types of gadolinium most often associated with this condition and the indications for withholding gadolinium are important and are discussed in this article. The use of enteric contrast agents and contrast agents during pregnancy and nursing are reviewed briefly. Current knowledge for safe use of contrast media and key concepts that all radiologists should know are summarized in this review.
Adverse reactions to gadolinium contrast media: a review of 36 cases.

K J Murphy,J A Brunberg,R H Cohan

DOI: https://doi.org/10.2214/ajr.167.4.8819369

1996-10-01

American Journal of Roentgenology

Abstract:OBJECTIVE: We investigated the frequency, manifestations, and severity of reactions to gadolinium contrast media in patients who underwent MR imaging at a single institution.MATERIALS AND METHODS: We reviewed the quality assurance records of 21,000 patients to whom gadolinium contrast media were administered at our institution between January 1990 and October 1994. Of these patients, 36 had adverse reactions. All 36 patients were evaluated by a radiologist at the time of the adverse reaction, and a written report of the findings was completed immediately.RESULTS: We classified adverse reactions into four groups: mild nonallergic reactions (15 patients with nausea or vomiting), mild reactions resembling allergy (12 patients with hives, diffuse erythema, or skin irritation), moderate reactions resembling allergy (seven patients with respiratory symptoms), and life-threatening reactions resembling allergy (two patients with severe chest tightness, respiratory distress, and periorbital edema). Eleven of these 36 patients who had adverse reactions also had an unusual local reaction of skin discomfort in the extremity through which gadolinium was injected. Four of the 36 patients with adverse reactions had histories of adverse reactions to iodinated contrast media. All four of these patients and one of the remaining 32 patients with adverse reactions required treatment. No patients with adverse reactions died.CONCLUSION: Although gadolinium contrast media are safe, we found that patients had adverse reactions at a frequency greater than we expected. Severe anaphylactoid reactions occurred in two patients (0.01%). This rate exceeds the rate of 0.0003% reported in the literature. The indexes of suspicion for the occurrence of reactions to gadolinium, and both the documentation and the management of adverse reactions, must be as rigorous for reactions associated with MR imaging contrast agents as they are for reactions associated with iodinated contrast media.

radiology, nuclear medicine & medical imaging
Management of acute adverse reactions to contrast media

Henrik S. Thomsen,Sameh K. Morcos,Members of Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR)

DOI: https://doi.org/10.1007/s00330-003-2214-z

IF: 7.034

2004-03-01

European Radiology

Abstract:When anaphylactoid and other severe adverse reactions to contrast media occur, prompt recognition and immediate treatment are essential. Simple guidelines for treatment have been requested by many radiologists, and therefore the Contrast Media Safety Committee has produced guidelines for treatment of acute adverse reactions to contrast media. The committee made an extensive review of the literature on treatment of adverse reactions to contrast media. Based on this, a report and guidelines were prepared. The resulting report was discussed at the 10th European Symposium on Urogenital Radiology in Uppsala. Sweden, September 2003. Guidelines for treatment of acute adverse reactions and a list of first-line drugs and equipment that should be available in the room where contrast medium is given are provided.

radiology, nuclear medicine & medical imaging
A new Doppler spread estimation algorithm based on zero crossings of the auto-correlation

G. A. Ali,Shahid Manzoor,V. Jeoti

DOI: https://doi.org/10.1109/ICIAS.2010.5716204

2010-06-15

Abstract:The Doppler spread, or evenly, the mobile speed of motion, is an evaluation of the spectral spreading of mobile fading channel. A precise estimation of the mobile speed and/or velocity is of great significance in wireless mobile applications which needs the acquaintance of the rate of the channel variations. In this article we propose the use of the auto-correlation of the in-phase component of the received signal to estimate the maximum Doppler shift of the mobile communication system. The proposed algorithm relies on the zero crossing point of the auto-correlation function of the in-phase part of the received signal. A comparison between our proposed algorithm and the algorithm proposed by Tevfik Yucek in term of the Normalized Mean Square Error has been shown.
Adverse Reactions after the Use of SonoVue Contrast Agent

C. Hu,Feng Ying-er,Pintong Huang,Jingfen Jin

DOI: https://doi.org/10.1097/md.0000000000017745

IF: 1.6

2019-01-01

Medicine

Abstract:The aim of this study was to analyze the clinical manifestations of adverse reactions after the use of SonoVue contrast agent from a large retrospective database, and to evaluate the nursing care strategies and the efficacy of standardized procedure for adverse reactions of SonoVue (SPARS). From January 1, 2012 to December 30, 2018, 34,478 cases of contrast-enhanced ultrasonography were performed in our center. The clinical manifestations of adverse reactions after the use of SonoVue contrast agent were identified and analyzed. The nursing care strategies were evaluated and the outcomes of patients with moderate and severe adverse reactions before and after the application of SPARS were compared. Of the 34,478 cases, 40 cases (0.12%) of adverse reactions after the use of SonoVue were identified. Adverse reactions included anaphylatic shock, skin allergies, nausea or vomiting, dizziness or headache, numbness, chest distress, back pain, and local reactions of the injection site. Most of the adverse reactions were mild and self-limited. Only 3 cases of anaphylatic shock and 2 cases of severe rash underwent further treatments. The 3 patients who were managed by SPARS recovered quicker and spent less comparing with the other 2 patients who were not. SonoVue was a safe contrast agent, with few and mostly mild adverse reactions. SPARS may be an efficient way in tackling moderate to severe adverse reactions, although of which the incidence was rare.
The effect of thyroid-stimulating hormone in acute thyroiditis.

Jacob Robbins,J. Rall,J. Trunnell,Rulon W. Rawson

DOI: https://doi.org/10.1210/JCEM-11-10-1106

1951-10-01

Abstract:ACUTE thyroiditis, also referred to as acute diffuse thyroiditis, acute nonsuppurative thyroiditis, and subacute thyroiditis, is an inflammatory disease characterized by fever, malaise, and a firm and very tender enlargement of the thyroid gland. The etiology is unknown. Recent studies (1, 2, 3) have disclosed that acute thyroiditis is accompanied by a striking decrease in the ability of the thyroid to concentrate radioiodine after a tracer dose, and by a high normal or slightly elevated serum proteinbound iodine (PBI). Although the diagnosis of this disease is usually clearcut on clinical grounds alone, the uptake of radioiodine by the thyroid and the serum PBI may be of value in differentiating acute thyroiditis from hemorrhage into an adenoma of the thyroid or from a neoplasm of the thyroid. Other situations in which a greatly depressed uptake of radioiodine and a normal or elevated serum PBI may coexist are those following the administration of iodine or iodine-containing substances, such as desiccate...
Frequently Asked Questions: Iodinated Contrast Agents

Michael A Bettmann,Michael A. Bettmann

DOI: https://doi.org/10.1148/rg.24si045519

2004-10-01

Radiographics

Abstract:Although iodinated contrast agents are safe and widely used, adverse events occur and questions remain about their use, safety, and interactions. Some questions are easily answered and others still require extensive investigation. For one frequent question--is informed consent necessary before all contrast media injections--the simple answer is no. Another question concerns use of contrast media in patients with prior reactions or allergies. Contrast agents can be safely used in such patients, but special care must be taken to be aware of what the previous reaction was and to be ready to treat any reaction. The protective role of pre-treatment with steroids is well established for minor reactions, but they may not prevent major reactions. It is important to realize that even life-threatening, anaphylactoid reactions are not the result of a true allergy to contrast media. Many questions arise about contrast agent-induced nephropathy. Baseline serum creatinine values should be obtained in patients who are at risk, not all patients. The incidence and natural history of contrast agent-induced nephropathy remain unclear. It occurs only in patients with compromised renal function before contrast agent injection, but even patients with normal serum creatinine levels can have renal dysfunction. Calculated creatinine clearance is a better way to determine risk and to follow this complication. The outcome in almost all patients is benign, with progression to end-stage renal disease being rare. The major risk factors, in addition to renal dysfunction, are long-standing diabetes mellitus, dehydration, and use of other nephrotoxic medications. Recent work in preventing and ameliorating contrast agent-induced nephropathy with N-acetyl cysteine, substitution of an isosmolal nonionic contrast agent, and various hydration regimens has been promising. Another common concern is use of iodinated contrast agents in pregnant or breast-feeding women. In both cases, there is no evidence of harm to the fetus or infant, but it is prudent to weigh the theoretical risks and benefits and avoid contrast agent administration unless it is truly necessary.

radiology, nuclear medicine & medical imaging
Contrast media safety-an update

Henrik S Thomsen

DOI: https://doi.org/10.1016/j.ejrad.2010.12.104

Abstract:The value of contrast agents has for long been documented by their common daily use in imaging departments worldwide. In principle, they should be injected and leave the body immediately after use in the same condition or undergo natural metabolism without making any harm to the patient. However, this is not the case. It is of utmost importance to reduce the prevalence to as close as possible to zero. This can be done by identifying the patients at risk before administration of contrast agents. For acute non-renal adverse reactions, it is also important to be prepared for treating them instantly. The current review is a short state of the art regarding adverse reactions to contrast agents.
Iodinated Contrast Media and Their Adverse Reactions

Jagdish Singh,Aditya Daftary,J. Singh,A. Daftary

DOI: https://doi.org/10.2967/jnmt.107.047621

2008-05-15

Journal of Nuclear Medicine Technology

Abstract:Cross-use of technology between nuclear medicine and radiology technologists is expanding. The growth of PET/CT and the increasing use of intravenous contrast agents during these procedures bring the nuclear medicine technologist into direct contact with these agents and their associated complications. A basic understanding of the occurrence, risk factors, clinical features, and management of these procedures is of increasing importance to the nuclear medicine technologist. After reading this article, the technologist will be able to list the factors that increase the risk of contrast reactions; understand ways to minimize the occurrence of contrast reactions; and develop a plan to identify, treat, and manage the reactions effectively.
Intravenous Imaging Contrast Media Complications: The Basics That Every Clinician Needs to Know

Trevor A Rose Jr,Jung W Choi

DOI: https://doi.org/10.1016/j.amjmed.2015.02.018

Abstract:Intravenous contrast is commonly used in noninvasive imaging procedures such as magnetic resonance imaging and computed tomography and can evaluate blood vessels and better characterize soft-tissue lesions. Although the incidence of adverse events after administration of contrast is low, it is important that clinicians and radiologists minimize risks and respond quickly and effectively when reactions occur. We will discuss a range of adverse events to iodinated and gadolinium-based contrast agents, including allergic-like reactions, nephrotoxicity, extravasation, and nephrogenic systemic fibrosis. We will review risk stratification for patients, as well as premedication and treatment of adverse events.
Retrospective analysis of non-laboratory-based adverse drug reactions induced by intravenous radiocontrast agents in a Joint Commission International-accredited academic medical center hospital in China

Qin-Lan Chen,Xiao-Ying Zhao,Xiao-Mi Wang,Na Lv,Ling-Ling Zhu,Hui-Min Xu,Quan Zhou

DOI: https://doi.org/10.2147/TCRM.S134265

2017-04-26

Abstract:The authors retrospectively analyzed the pattern and characteristics of non-laboratory-based adverse drug reactions (ADRs) induced by intravenous radiocontrast agents in a large-scale hospital in China during 2014-2015. There were 314 ADR cases among 118,208 patients receiving enhanced CT or MRI examinations. The frequency of moderate/severe ADRs defined by Chinese Society of Radiology (ie, severe vomiting, systematic urticaria, facial swelling, dyspnea, vasovagal reaction, laryngeal edema, seizure, trembling, convulsions, unconsciousness, shock, death, and other unexpected adverse reactions) was rare (0.0431%), whereas the mild ADRs were uncommon (0.2225%) and accounted for 83.76% of ADRs. Frequency of ADRs induced by iodinated contrast agents was related with examination site, sex, and type of patient settings (P<0.01) and was higher compared with gadolinium contrast agents (0.3676% vs 0.0504%, P<0.01). From 2014 to 2015, frequencies of total and moderate/severe ADRs induced by iodinated contrast agents decreased significantly (0.4410% vs 0.2947%, P<0.01; 0.0960% vs 0.0282%, P<0.01, respectively). Frequency of ADRs differed among different iodinated contrast and gadolinium contrast (P<0.05) agents. Iopromide's ADR frequency in 2014 was significantly higher compared with iopamidol, ioversol, or iohexol (P<0.01). Frequency of moderate/severe ADRs induced by iodixanol was 4.1-5.4 times that of iohexol, iopromide, or iopamidol. Rash was the predominant ADR subtype (84.39%) and occurred more frequently with iodixanol compared with iohexol, iopamidol, or ioversol (P<0.01). Overall, 21.97% of ADR cases had allergy history or atopy traits, and these cases experienced ADRs earlier than the negative ones (17.19 min vs 85.34 min, P<0.01). The mean time to onset of ADRs was increased in patients receiving iodixanol compared with other iodinated contrast agents (323.77 min vs 42.36 min, P<0.01). Overall, 37.26% of ADRs occurred within 5 min and 84.08% of ADRs occurred within 30 min. Efficient quality improvement in decreasing ADRs induced by radiocontrast agents has been achieved by multidisciplinary collaboration.

A new mutant in the yellow-bellied cotton rat.

Prevention and Treatment of Anaphylactoid Reaction to Ionic and Nonionic Iodinated Contrast Media

Managing Adverse Reactions to Contrast Agents

Adverse Reactions to Contrast Material: A Canadian Update

Prevention and Management of Adverse Reactions Induced by Iodinated Contrast Media

[Prophylaxis and treatment of side effects due to iodinated contrast media relevant to radiological practice]

Intrinsic alterations of pro‐inflammatory mediators in unstimulated and TLR‐2 stimulated keratinocytes from atopic dermatitis patients

Iodine and Gadolinium Contrast Reactions: What Is the Risk and Role of Premedication, Abbreviated Protocols, Prior History of Reactions, and Cross-Reactivity?

Trends in Adverse Events After IV Administration of Contrast Media

On q-Integral Transforms and Their Applications

Safe Use of Contrast Media: What the Radiologist Needs to Know

Adverse reactions to gadolinium contrast media: a review of 36 cases.

Management of acute adverse reactions to contrast media

A new Doppler spread estimation algorithm based on zero crossings of the auto-correlation

Adverse Reactions after the Use of SonoVue Contrast Agent

The effect of thyroid-stimulating hormone in acute thyroiditis.

Frequently Asked Questions: Iodinated Contrast Agents

Contrast media safety-an update

Iodinated Contrast Media and Their Adverse Reactions

Intravenous Imaging Contrast Media Complications: The Basics That Every Clinician Needs to Know

Retrospective analysis of non-laboratory-based adverse drug reactions induced by intravenous radiocontrast agents in a Joint Commission International-accredited academic medical center hospital in China